Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAPIS: Oral Versus Intravenous Iron for Anemia Diagnosed After 34 Weeks of Gestation
NCT07485023Not yet recruiting
- Sponsor
- Sapienza University of Rome
- Start
- Jul 2026
- Primary completion
- Jul 2028
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of Iron in anemia (2 arms), sponsored by Sapienza University of Rome. Primary endpoint: Hemoglobin concentration at hospital admission for delivery. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
Iron
03
Conditions
anemia
Beyond the preview
Go deeper on NCT07485023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07485023.